Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
JAMA
|
October 29, 2009
DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model
Doris Lambracht-Washington, Bao-Xi Qu, Min Fu, et al.
Journal of the Neurological Sciences
|
August 21, 2007
Prion proteins: physiological functions and role in neurological disorders
Wei Hu, Bernd Kieseier, Elliot Frohman, et al.
Plos One
|
August 9, 2018
Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis
Matthew Cummings, Anitha Christy Sigamani Arumanayagam, Picheng Zhao, et al.
Clinical Transplantation
|
March 20, 2023
Deceased donor vein extension grafts for right living donor kidney transplantation
Andrea M Meinders, Richard Knight, Todd N Eagar, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 10, 2004
CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance
Todd N Eagar, Danielle M Turley, Josette Padilla, et al.
Cellular and Molecular Neurobiology
|
June 1, 2011
DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation
Doris Lambracht-Washington, Bao-Xi Qu, Min Fu, et al.
Journal of Neuroimmunology
|
October 6, 2012
A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease
Doris Lambracht-Washington, Bao-xi Qu, Min Fu, et al.
Clinical Transplantation
|
May 21, 2026
Long-Term Outcomes of Renal Transplant Allografts With De Novo DSA in the Setting of Stable Function
Richard J Knight, Edward A Graviss, Duc T Nguyen, et al.
Clinical Transplantation
|
June 6, 2017
The detrimental impact of persistent vs an isolated occurrence of de novo donor-specific antibodies on intermediate-term renal transplant outcomes
Jennifer M Loucks-DeVos, Todd N Eagar, A Osama Gaber, et al.
Journal of Neuroimmunology
|
September 18, 2014
Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance
Cyd Castro-Rojas, Krystin Deason, Rehana Z Hussain, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
JAMA
|
October 29, 2009
DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model
Doris Lambracht-Washington, Bao-Xi Qu, Min Fu, et al.
Journal of the Neurological Sciences
|
August 21, 2007
Prion proteins: physiological functions and role in neurological disorders
Wei Hu, Bernd Kieseier, Elliot Frohman, et al.
Plos One
|
August 9, 2018
Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis
Matthew Cummings, Anitha Christy Sigamani Arumanayagam, Picheng Zhao, et al.
Clinical Transplantation
|
March 20, 2023
Deceased donor vein extension grafts for right living donor kidney transplantation
Andrea M Meinders, Richard Knight, Todd N Eagar, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 10, 2004
CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance
Todd N Eagar, Danielle M Turley, Josette Padilla, et al.
Cellular and Molecular Neurobiology
|
June 1, 2011
DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation
Doris Lambracht-Washington, Bao-Xi Qu, Min Fu, et al.
Journal of Neuroimmunology
|
October 6, 2012
A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease
Doris Lambracht-Washington, Bao-xi Qu, Min Fu, et al.
Clinical Transplantation
|
May 21, 2026
Long-Term Outcomes of Renal Transplant Allografts With De Novo DSA in the Setting of Stable Function
Richard J Knight, Edward A Graviss, Duc T Nguyen, et al.
Clinical Transplantation
|
June 6, 2017
The detrimental impact of persistent vs an isolated occurrence of de novo donor-specific antibodies on intermediate-term renal transplant outcomes
Jennifer M Loucks-DeVos, Todd N Eagar, A Osama Gaber, et al.
Journal of Neuroimmunology
|
September 18, 2014
Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance
Cyd Castro-Rojas, Krystin Deason, Rehana Z Hussain, et al.
Page
of 6